Equities

Industri Jamu dan Farmasi Sido Muncul Tbk PT

  • Add to watchlist
  • Add to portfolio
  • Add an alert
SIDO:JKT

Industri Jamu dan Farmasi Sido Muncul Tbk PT

Actions
Consumer Staples Food Producers
  • Price (IDR)488.00
  • Today's Change0.00 / 0.00%
  • Shares traded6.07m
  • 1 Year change-34.50%
  • Beta0.1163
Data delayed at least 10 minutes, as of Jul 07 2025 10:13 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

PT Industri Jamu Dan Farmasi Sido Muncul Tbk is an Indonesia-based company, which carries out business activities in herbal industry, such as medical industry (pharmacy), herbs, cosmetics, foods and beverages related to health, commerce, land transportation, services, wastewater treatment, plantation, and printing. The Company's segments include Herbal medicine and supplement, Food and beverages, and Pharmacy. The Company’s products include Tolak Angin Cair, Tolak Angin Anak + Madu, Tolak Angin Flu, Tolak Angin Sugar Free, Sido Muncul Tolak Linu, Kuku Bima Ener-G!, Susu Jahe, Kopi Jahe, Sido Muncul C-1000 (Dengan Ekstrak Lemon), Esemag, Sari Kunyit Soft Capsule, Tolak Angin Soft Capsule, Tolak Linu Soft Capsule, JSH Capsule, VCO Soft Capsule, Sido Muncul Vitamin D3 400 IU, Sido Muncul VItamin E 100 IU, Sido Muncul Vitamin E 300 IU, Minuman Madu dengan Jahe maduSido, Tolak Angin Care, Tolak Linu Cool, Anak Sehat Rasa Anggur, Anak Sehat Rasa Coklat, and Anak Sehat Rasa Jambu Merah.

  • Revenue in IDR (TTM)3.65tn
  • Net income in IDR1.01tn
  • Incorporated1981
  • Employees3.60k
  • Location
    Industri Jamu dan Farmasi Sido Muncul Tbk PTGedung Menara Suara Merdeka 16th FloorJl. Pandanaran No. 30SEMARANG 50134IndonesiaIDN
  • Phone+62 2 476928811
  • Fax+62 2 476928815
  • Websitehttps://www.sidomuncul.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Jiangsu Aidea Pharmaceutical Co Ltd1.18tn-253.02bn13.74tn704.00--6.11--11.64-0.2662-0.26621.242.370.28660.93553.09742,572.90-5.46-4.33-8.57-5.3658.5340.16-19.06-20.350.9916--0.32--1.573.89-85.63--5.88--
Hunan Warrant Pharmaceutical Co Ltd3.11tn328.61bn13.82tn1.24k42.063.30--4.451.111.1110.4814.110.5811.427.971,111,697.005.219.476.2111.6159.4467.038.9613.012.71--0.077414.11-1.3811.37-22.247.2157.23--
CorMedix Inc1.34tn278.06bn13.98tn64.0051.576.8548.9810.460.22530.22531.341.700.75870.8093--1,289,904.0015.79-42.8519.78-49.8295.1991.9320.81-327.993.99--0.00----173.6561.31--25.91--
Avadel Pharmaceuticals PLC (ADR)3.15tn-427.45bn14.01tn188.00--11.65--4.45-0.2743-0.27432.020.76651.161.206.051,034,309.00-15.73-42.00-22.28-50.5390.06---13.58-194.152.33-1.850.00--504.7923.3569.53------
China Shineway Pharmaceutical Group Ltd8.53tn1.90tn14.12tn3.22k6.800.83758.841.661.221.225.489.890.38521.114.531,284,835.008.578.2911.4010.3874.9574.8322.2418.673.18--0.044437.49-16.356.90-13.3510.808.9219.39
EIS czcbs lc Sn v Fnnsl Ytrmlr Sny v Tcr3.26tn787.83bn14.13tn1.05k17.930.682712.814.332.832.8311.7274.340.13952.835.857,380,610.003.376.403.656.8631.6133.3124.1640.471.89--0.0634---6.2858.48-74.1244.46151.5688.80
Polypeptide Group AG6.46tn-372.87bn14.19tn1.29k--2.0863.822.20-0.5541-0.55419.5610.120.46872.184.11245,367.10-2.710.555-3.640.709911.6119.25-5.781.050.935-0.68310.22762.374.2810.7061.97--34.57--
Hbm Holdings Ltd616.64bn44.96bn14.30tn156.00296.896.29156.9723.180.02830.02830.38611.330.17183.781.241,917,163.001.24-42.871.77-53.2488.2396.127.20-292.582.792.190.3309---57.4347.71-87.81---55.31--
Industri Jamu dn Frms Sd Mncl Tbk PT3.65tn1.01tn14.64tn3.60k14.443.9412.994.0133.7933.79121.84123.720.87533.564.591,025,467,000.0024.2727.6226.7231.6957.1456.7027.7328.985.45--0.000997.089.905.0223.187.71-19.129.91
Data as of Jul 07 2025. Currency figures normalised to Industri Jamu dan Farmasi Sido Muncul Tbk PT's reporting currency: Indonesian Rupiah IDR

Institutional shareholders

3.60%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 04 Jun 2025221.03m0.74%
eQ Varainhoito Oyas of 31 Jan 2024209.15m0.70%
Dimensional Fund Advisors LPas of 05 Jun 2025120.40m0.40%
First Sentier Investors (UK) IM Ltd.as of 30 Apr 2025108.08m0.36%
Mellon Investments Corp.as of 06 Jun 202599.20m0.33%
BlackRock Fund Advisorsas of 05 Jun 202586.24m0.29%
Templeton Investment Counsel LLCas of 30 May 202577.31m0.26%
TIAA-CREF Investment Management LLCas of 30 Apr 202563.68m0.21%
AllianceBernstein Ltd.as of 31 Mar 202553.84m0.18%
Franklin Templeton Investments (Asia) Ltd.as of 30 Sep 202441.05m0.14%
More ▼
Data from 31 Jan 2024 - 02 Jul 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.